DAEWOONG CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18,300 KRW | -1.82% |
|
-5.03% | -11.38% |
| 04-24 | Korean Sugar Imports Plunge 14% as Diabetes Cases Surge | MT |
| 03-08 | Daewoong Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2019 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | 559,241 | 846,180 | 846,161 | 748,300 | - |
| Enterprise Value (EV) 2 | 559.2 | 846.2 | 1,039 | 946.9 | 860.7 |
| P/E ratio | 8.96 x | 8.25 x | - | - | - |
| Yield | - | - | - | 0.55% | 0.55% |
| Capitalization / Revenue | - | - | 0.47 x | 0.4 x | 0.36 x |
| EV / Revenue | - | - | 0.57 x | 0.5 x | 0.41 x |
| EV / EBITDA | - | - | 4.16 x | 2.73 x | 2.13 x |
| EV / FCF | - | - | 42.9 x | 19.1 x | 9.88 x |
| FCF Yield | - | - | 2.33% | 5.23% | 10.1% |
| Price to Book | - | - | 0.9 x | 1.52 x | 1.21 x |
| Nbr of stocks (in thousands) | 43,185 | 41,581 | 40,976 | 40,891 | - |
| Reference price 3 | 12,950 | 20,350 | 20,650 | 18,300 | 18,300 |
| Announcement Date | 3/5/20 | 3/8/23 | 2/13/24 | - | - |
1KRW in Million2KRW in Billions3KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | - | - | 1,814 | 1,883 | 2,082 |
| EBITDA 1 | - | - | 249.8 | 347.3 | 403.5 |
| EBIT 1 | - | - | 195.6 | 291.4 | 343.8 |
| Operating Margin | - | - | 10.78% | 15.48% | 16.51% |
| Earnings before Tax (EBT) | - | - | - | - | - |
| Net income | 62.44 | 102.6 | - | - | - |
| Net margin | - | - | - | - | - |
| EPS | 1,446 | 2,467 | - | - | - |
| Free Cash Flow 2 | - | - | 24,211 | 49,500 | 87,100 |
| FCF margin | - | - | 1,334.81% | 2,629.34% | 4,183.28% |
| FCF Conversion (EBITDA) | - | - | 9,691.23% | 14,252.81% | 21,586.12% |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share 3 | - | - | - | 100.0 | 100.0 |
| Announcement Date | 3/5/20 | 3/8/23 | 2/13/24 | - | - |
1KRW in Billions2KRW in Million3KRW
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q3 | 2023 Q4 |
|---|---|---|
| Net sales | 461.5 | - |
| EBITDA | - | - |
| EBIT 1 | - | 14.25 |
| Operating Margin | - | - |
| Earnings before Tax (EBT) | - | - |
| Net income | - | - |
| Net margin | - | - |
| EPS | - | - |
| Dividend per Share | - | - |
| Announcement Date | 11/14/23 | 2/13/24 |
1KRW in Billions
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | 193 | 199 | 112 |
| Net Cash position 1 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | 0.7738 x | 0.5718 x | 0.2786 x |
| Free Cash Flow 2 | - | - | 24,211 | 49,500 | 87,100 |
| ROE (net income / shareholders' equity) | - | - | 13.9% | 26.1% | 25.3% |
| ROA (Net income/ Total Assets) | - | - | 6.76% | 10.8% | 11.6% |
| Assets | - | - | - | - | - |
| Book Value Per Share 3 | - | - | 22,861 | 12,073 | 15,135 |
| Cash Flow per Share | - | - | - | - | - |
| Capex 1 | - | - | 181 | 75.4 | 83.4 |
| Capex / Sales | - | - | 10% | 4.01% | 4.01% |
| Announcement Date | 3/5/20 | 3/8/23 | 2/13/24 | - | - |
1KRW in Billions2KRW in Million3KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
18,300
KRW
Average target price
25,000
KRW
Spread / Average Target
+36.61%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -11.38% | 560M | |
| +22.35% | 44.12B | |
| +22.22% | 22.61B | |
| +17.81% | 15.11B | |
| +15.73% | 13.61B | |
| +57.91% | 13.34B | |
| -8.98% | 6.94B | |
| -0.05% | 6.79B | |
| +15.65% | 5.75B | |
| -8.87% | 5.73B |
- Stock Market
- Equities
- A003090 Stock
- Financials Daewoong Co., Ltd.